Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gogoro Inc (GGR) vs GeneDx Holdings Corp (WGS) Price & Performance

Gogoro IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Gogoro Inc vs GeneDx Holdings Corp — how do they compare? Gogoro Inc trades at $3.8 (market cap $77.38M), while GeneDx Holdings Corp trades at $61.39 (market cap $1.96B). The key difference: GeneDx Holdings Corp is far larger — about 25.3× Gogoro Inc's market cap. Which is the better fit depends on your goals.

GGRWGS
Market Cap
$77.38M$1.96B
Sector
TechnologyTechnology
52-Week High
$7.89$167.51
52-Week Low
$2.74$34.51
Enterprise Value
$379.83M$1.96B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gogoro Inc

Gogoro Inc. (GGR) trades at $3.86, up 1.58% on the day, but remains in a technically bearish trend. Fundamentally, the company reported Q1 2026 results highlighting improved margins and positive operating cash flow, though it continues to post significant net losses with a -24.68% net income margin. The analyst consensus is unanimously neutral with a 100% Hold rating, reflecting caution despite recent operational progress.

The outlook is mixed. Opportunities stem from Gogoro's growing battery-swapping subscriber base and expansion into new markets like Vietnam. However, significant risks persist, including sustained unprofitability, high cash burn with a net cash flow of -$46.57M in 2025, and negative shareholder returns evidenced by a -50.38% ROE. The stock's low P/S of 0.21 suggests the market has heavily discounted its growth prospects.

GeneDx Holdings Corp

WGS trades at $62.73, up 0.48% on the day, amid a bearish technical signal and negative earnings momentum. The stock faces significant headwinds from a class action lawsuit alleging securities fraud tied to a 49% stock decline, while fundamentals show a net loss of $21.02 million in 2025 and deteriorating profitability into 2026. Analyst consensus remains bullish with a $75.40 price target, but recent news flow is overwhelmingly negative.

The outlook is clouded by legal risks and weak financial performance, though analyst optimism suggests potential recovery if the company can stabilize operations. Key risks include litigation outcomes, execution on profitability, and market sentiment shifts. The stock's trajectory hinges on resolving legal challenges and demonstrating sustainable earnings improvement.

Returns comparison

Trailing returns across standard periods

About Gogoro Inc

Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.

Read more on GGR

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS